Commentary
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
-
* Corresponding author: Erica L Mayer emayer@partners.org
Breast Cancer Research 2007, 9:110 doi:10.1186/bcr1755
No comments have yet been made on this article.